BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 14, 2017
View Archived Issues
Molecular Partners updates pipeline progress
Read More
Novel antibody against TGF-beta1 shows efficacy without cardiotoxicity in fibrosis model
Read More
TP-0469711 demonstrates promising activity as a new therapeutic for hyperphosphatemia
Read More
EMA grants positive opinion for Ocrevus as treatment for patients with RMS or PPMS
Read More
Homology Medicines enters R&D collaboration with Novartis
Read More
EMA recommends Prevymis for marketing authorization
Read More
Theravance Biopharma and Mylan submit NDA in U.S. for revefenacin
Read More
Shire's Adynovi receives positive opinion in E.U.
Read More
IDX-1197 demonstrates efficacy in models of ovarian cancer
Read More
EMA committee backs approval of Jorveza as treatment for eosinophilic esophagitis
Read More
EMA confirms further restrictions on use of Zinbryta
Read More
QS-1189 inhibits tumor growth in preclinical cancer models
Read More
EMA grants orphan drug designation to Debio-1347
Read More
Rodin Therapeutics awarded grant from Michael J. Fox Foundation
Read More
Phase II data presented for MEDI-6012 in patients with coronary heart disease
Read More
PRD-125: a potent SOAT2 inhibitor ameliorates atherosclerosis in rabbits
Read More
EMA grants accelerated assessment to patisiran for hereditary ATTR amyloidosis
Read More
Akcea initiates phase II program with AKCEA-ANGPTL3-LRx in rare hyperlipidemias
Read More
OncBioMune reports new data from phase I ProscaVax study
Read More
Positive interim results for phase I trial of ISC-hpNSC in Parkinson's disease
Read More
Phase I results reported for Bristol-Myers Squibb candidate for autoimmune diseases
Read More
FDA approves digital medicine system Abilify Mycite
Read More
Spero Therapeutics identifies novel antibiotic potentiators
Read More
Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical Group patent IDO-1/TDO inhibitors
Read More
Merck & Co. and IOmet Pharma discover novel IDO-1/TDO inhibitors
Read More
Dana-Farber Cancer Institute presents anti-CDK9 and CDK8 proteolysis targeting chimera compounds
Read More